XXXX and @entity1652 opica: A causal link.

@entity1652 @entity1 @entity6220 @entity1737
@entity1652 ( @entity1652 ) and @entity1737 ( @entity1737 ) are rare antibody mediated @entity6220 (NMJ) respectively. Both diseases are predominantly mediated by IgG1 antibodies that activate complement. There have been increasing reports of @entity1 who develop both disorders. Given the rarity of both diseases it would seem that these occurrences are not purely coincidental. There is heterogeneity between the cases described in the literature but common trends are observed in @entity1 who develop both disorders. Most @entity1 described are female. Typically the @entity1737 precedes the @entity1652 and the majority of @entity1 have undergone thymectomy. Generally, the symptoms of @entity1737 are mild but the @entity1652 tends to follow a more aggressive clinical course. The pathogenesis of @entity1652 in combination with @entity1737 is unknown, but thymectomy has been implicated in a subset of @entity1 . We present the case of a female @entity1 who developed @entity1652 on a background of sero-positive @entity1737 and discuss the relevant literature.
